ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer

ClinicalTrials.gov ID: NCT00003309

Public ClinicalTrials.gov record NCT00003309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Preradiation Multiagent Chemotherapy for Adults With "Poor Risk" Medulloblastoma, PNET, and Disseminated Ependymoma

Study identification

NCT ID
NCT00003309
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
33 participants

Conditions and interventions

Interventions

  • adjuvant therapy Procedure
  • cisplatin Drug
  • cyclophosphamide Drug
  • etoposide Drug
  • filgrastim Biological
  • radiation therapy Radiation
  • vincristine sulfate Drug

Procedure · Drug · Biological + 1 more

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 3, 1999
Primary completion
Feb 29, 2004
Completion
Not listed
Last update posted
Jun 21, 2023

Started 1999

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611-4494
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
West Michigan Cancer Center Kalamazoo Michigan 49007
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-6307
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226-3596

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2023 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003309 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →